CG
TTPH

Cutler Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Cutler Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-165
Closed -$2K – 5622
2017
Q4 		$2K Sell
165
-1,325
-89% -$170K ﹤0.01% 4293
2017
Q3 		$7K Buy
1,490
+75
+5% +$10K ﹤0.01% 4164
2017
Q2 		$39K Sell
1,415
-3,010
-68% -$465K ﹤0.01% 2755
2017
Q1 		$182K Buy
4,425
+3,740
+546% +$419K 0.01% 1268
2016
Q4 		$3K Sell
685
-140
-17% -$11.1K ﹤0.01% 5463
2016
Q3 		$3K Sell
825
-535
-39% -$42.9K ﹤0.01% 5530
2016
Q2 		$5K Buy
1,360
+475
+54% +$43.5K ﹤0.01% 5019
2016
Q1 		$13K Sell
885
-3,025
-77% -$302K ﹤0.01% 3793
2015
Q4 		$53K Buy
+3,910
New +$780K ﹤0.01% 2395

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's TTPH Position: Q1 2019 in Review

Cutler Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2019, closing a stake of 5 shares.

Cutler Group first reported a position in TTPH in Q4 2015 and held it in 13 quarters. The position peaked at $157K in Q1 2016. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • Cutler Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 5 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019.
  • Cutler Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 13 quarters.
  • Cutler Group's Tetraphase Pharmaceuticals, Inc. position peaked at $157K in Q1 2016.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.